Version 3 Published: April 2012 Review Date: April 2015
Current YCN Breast Cancer Pathway Pathway
Notes Key i - Information points Key discussion points a - Holistic Assessment – will include ‘exit’ assessment Key Worker identification /involvement
Patient identifies symptoms
Assessment in Primary care I
Direct access to imaging (u/s and mammography)
Screening & assessment i
Quality Criteria 1 Referrals in accordance with NICE and local referral criteria
Max 14 days New patient Clinic
Clinic exam, consultation and history
I
Imaging, x-ray and or ultraound
Quality Criteria 2 To include: Immediate imaging plus Ability to perform needle biopsy at first visit
Needle histology and/or cytology
Max 7 days
Quality Criteria 3 Skill mix/competancy as per BASO Guidance
MDT
Preliminary results to patient and GP
Clinic Results to Patient I a
Diagnostic results (and possible staging) Additional/repeat tests as required
Pre-assessment i Surgery (+/reconstruction)
Surgery
Endocrine
Palliative and supportive Care i
Chemotherapy I
Clinic Results to patient and discuss options I a
Results to GP
Max 31 days
Primary Endocrine i
Quality Criteria 4 Weekly MDT constituted in accordance with Manual of Cancer Max 62 Services Standards
days
MDT Post-surgical pathology
Radiotherapy
Chemotherapy
Palliative and Supportive Care
Quality Criteria 5 In accordance with IOG
Results to GP and secondary care clinicians
MDT Follow Up (+/- reconstruction as a delayed procedure) Relapse patients return to MDT I a End of Life
Discharged +/- limited planned breast imaging
Quality Criteria 6 YCN Palliative and Supportive Care Strategy